Acorn Regulatory Monthly Newsletter: September 2016

We have just launched our new Acorn Regulatory monthly newsletter.  You can read all of the stories from the newsletter here.  If you are not already subscribing then sign up to receive the next edition.

1. The Implications of Brexit

We are slowly beginning to understand what a ‘Brexit’ actually means.  The UK, with a new Prime Minister and cabinet, is moving towards an EU exit.  What impact will that have for our industry? Our whitepaper takes a look at how the pharma, medical device,and clinical trial sectors might be impacted by the decision of the UK to leave the EU. Our experts are available to assist clients, both existing and new, with any issues that arise from the ‘Brexit’ decision. Call us today on 00353 52 61 76706 or email us by clicking the link. The whitepaper is available to download here.

2. New Website

Our new website is now live.  It highlights our service areas, opinion pieces from our industry leading consultants and a comprehensive news section.

3. We Are Hiring

We are currently recruiting for a Senior Regulatory Affairs Advisor for our Medical Devices department.

We are also recruiting on behalf of a number of clients.  These roles are in both pharmaceutical and medical device companies and are a mix of part-time and full-time roles. Click here to find out more.

4. Case Study

Since 2002 we have helped hundreds of clients to break through roadblocks that were hindering their ability to get their product to market. We work on their behalf liaising with the Competent Authority. Read more about this case study here.

5. EMA Introduces New Chapter to EU-GVP

The European Medicines Agency has added a new chapter (Product- or population-specific considerations II: Biological medicinal products) to its guidelines on good pharmacovigilance practices (EU-GVP). Read more about this news story here.

If you are not already subscribing to our newsletter, then you can subscribe here: